Thomas Koed Doktor

Dr. Thomas Koed Doktor

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2012 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAkio Masuda
Akio Masuda
HAHenriette Skovgaard Andersen
Henriette Skovgaard Andersen
TDThomas Koed Doktor
Thomas Koed Doktor
TOTakaaki Okamoto
Takaaki Okamoto
MIMikako Ito
Mikako Ito
KOKinji Ohno
Kinji Ohno
CUGBP1 and MBNL1 are developmentally regulated RNA-binding proteins that are causally associated with myotonic dystrophy type 1. We globally determined the in vivo RNA-binding sites of CUGBP1 and MBNL1. Interestingly, CUGBP1 and MBNL1 are both preferentially bound to 3′ UTRs. Analysis of CUGBP1- and MBNL1-bound 3′ UTRs demonstrated that both factors mediate accelerated mRNA decay and temporal profiles of expression arrays supported this. Role of CUGBP1 on accelerated mRNA decay has been previously reported, but the similar function of MBNL1 has not been reported to date. It is well established that CUGBP1 and MBNL1 regulate alternative splicing. Screening by exon array and validation by RT-PCR revealed position dependence of CUGBP1- and MBNL1-binding sites on the resulting alternative splicing pattern. This study suggests that regulation of CUGBP1 and MBNL1 is essential for accurate control of destabilization of a broad spectrum of mRNAs as well as of alternative splicing events.

1 March 2007 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KNKarsten Bork Nielsen
Karsten Bork Nielsen
SSSuzette Sørensen
Suzette Sørensen
LCLuca Cartegni
Luca Cartegni
TCThomas Croydon
Thomas Croydon
TDThomas Koed Doktor
Thomas Koed Doktor
BABrage Storstein Andresen
Brage Storstein Andresen

23 August 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
TDThomas Koed Doktor
Thomas Koed Doktor
YHYimin Hua
Yimin Hua
HAHenriette Skovgaard Andersen
Henriette Skovgaard Andersen
SBSabrina Brøner
Sabrina Brøner
YLYing Hsiu Liu
Ying Hsiu Liu
BABrage Storstein Andresen
Brage Storstein Andresen
Spinal Muscular Atrophy (SMA) is a neuromuscular disorder caused by insufficient levels of the Survival of Motor Neuron (SMN) protein. SMN is expressed ubiquitously and functions in RNA processing pathways that include trafficking of mRNA and assembly of snRNP complexes. Importantly, SMA severity is correlated with decreased snRNP assembly activity. In particular, the minor spliceosomal snRNPs are affected, and some U12-dependent introns have been reported to be aberrantly spliced in patient cells and animal models. SMA is characterized by loss of motor neurons, but the underlying mechanism is largely unknown. It is likely that aberrant splicing of genes expressed in motor neurons is involved in SMA pathogenesis, but increasing evidence indicates that pathologies also exist in other tissues. We present here a comprehensive RNA-seq study that covers multiple tissues in an SMA mouse model. We show elevated U12-intron retention in all examined tissues from SMA mice, and that U12-dependent intron retention is induced upon siRNA knock-down of SMN in HeLa cells. Furthermore, we show that retention of U12-dependent introns is mitigated by ASO treatment of SMA mice and that many transcriptional changes are reversed. Finally, we report on missplicing of several Ca2+ channel genes that may explain disrupted Ca2+ homeostasis in SMA and activation of Cdk5.

5 July 2016 in BMC Biology
Verified
Journal Article
Open access
PDF file
GBGitte H. Bruun
Gitte H. Bruun
TDThomas Koed Doktor
Thomas Koed Doktor
JBJonas Borch-Jensen
Jonas Borch-Jensen
AMAkio Masuda
Akio Masuda
AKAdrian R. Krainer
Adrian R. Krainer
BABrage Storstein Andresen
Brage Storstein Andresen
Many pathogenic genetic variants have been shown to disrupt mRNA splicing. Besides splice mutations in the well-conserved splice sites, mutations in splicing regulatory elements (SREs) may deregulate splicing and cause disease. A promising therapeutic approach is to compensate for this deregulation by blocking other SREs with splice-switching oligonucleotides (SSOs). However, the location and sequence of most SREs are not well known. Here, we used individual-nucleotide resolution crosslinking immunoprecipitation (iCLIP) to establish an in vivo binding map for the key splicing regulatory factor hnRNP A1 and to generate an hnRNP A1 consensus binding motif. We find that hnRNP A1 binding in proximal introns may be important for repressing exons. We show that inclusion of the alternative cassette exon 3 in SKA2 can be significantly increased by SSO-based treatment which blocks an iCLIP-identified hnRNP A1 binding site immediately downstream of the 5’ splice site. Because pseudoexons are well suited as models for constitutive exons which have been inactivated by pathogenic mutations in SREs, we used a pseudoexon in MTRR as a model and showed that an iCLIP-identified hnRNP A1 binding site downstream of the 5′ splice site can be blocked by SSOs to activate the exon. The hnRNP A1 binding map can be used to identify potential targets for SSO-based therapy. Moreover, together with the hnRNP A1 consensus binding motif, the binding map may be used to predict whether disease-associated mutations and SNPs affect hnRNP A1 binding and eventually mRNA splicing.

19 June 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AGAlexander Gulliver Bjørnholt Grønning
Alexander Gulliver Bjørnholt Grønning
TDThomas Koed Doktor
Thomas Koed Doktor
SLSimon Jonas Larsen
Simon Jonas Larsen
UPUlrika Simone Spangsberg Petersen
Ulrika Simone Spangsberg Petersen
LHLise Lolle Holm
Lise Lolle Holm
BABrage Storstein Andresen
Brage Storstein Andresen
Nucleotide variants can cause functional changes by altering protein–RNA binding in various ways that are not easy to predict. This can affect processes such as splicing, nuclear shuttling, and stability of the transcript. Therefore, correct modeling of protein–RNA binding is critical when predicting the effects of sequence variations. Many RNA-binding proteins recognize a diverse set of motifs and binding is typically also dependent on the genomic context, making this task particularly challenging. Here, we present DeepCLIP, the first method for context-aware modeling and predicting protein binding to RNA nucleic acids using exclusively sequence data as input. We show that DeepCLIP outperforms existing methods for modeling RNA-protein binding. Importantly, we demonstrate that DeepCLIP predictions correlate with the functional outcomes of nucleotide variants in independent wet lab experiments. Furthermore, we show how DeepCLIP binding profiles can be used in the design of therapeutically relevant antisense oligonucleotides, and to uncover possible position-dependent regulation in a tissue-specific manner. DeepCLIP is freely available as a stand-alone application and as a webtool at http://deepclip.compbio.sdu.dk.

30 November 2010 in Human Mutation
Verified
Journal Article
Closed access
PDF file
TDThomas Koed Doktor
Thomas Koed Doktor
LSLisbeth Dahl Schroeder
Lisbeth Dahl Schroeder
AVAnne Vested
Anne Vested
JPJohan Palmfeldt
Johan Palmfeldt
HAHenriette Skovgaard Andersen
Henriette Skovgaard Andersen
BABrage Storstein Andresen
Brage Storstein Andresen
Spinal Muscular Atrophy is caused by homozygous loss of SMN1 with phenotypic modulation by SMN2. SMN2 expresses only limited amounts of full-length transcript due to skipping of exon 7 caused by disruption of an SF2/ASF binding ESE. Additionally, hnRNP A1 has been reported to inhibit inclusion of SMN2 exon 7. We previously reported high similarity between the sequence spanning the 3′ ss of SMN1 and SMN2 exon 7 and an hnRNP A1 binding ESS, which regulates MCAD exon 5 splicing. We show here that this 3′ ss motif indeed functions as a crucial hnRNP A1 binding ESS, which inhibits inclusion of SMN1/2 exon 7 and is antagonized by the SMN1 ESE, but not by the inactive SMN2 sequence. Pull-down experiments revealed a specific interaction between hnRNP A1 and the 3′ ss AG-dinucleotide, which could be disrupted by mutations shown to improve splicing in reporter minigenes. Genomic analyses revealed that in the human genome, 3′ ss matching the SMN1/2 ESS motif region are much less abundant than 3′ ss with a disrupted ESS motif. This indicates that this ESS may be a general splicing inhibitory motif, which binds hnRNP A1 and inhibits exon inclusion by binding to 3′ ss harboring this ESS motif. Hum Mutat 32: 1-11, 2011.